Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Summary
S03576 would create a statewide fibroid study program within the New York State Department of Health. The commissioner would be required to study the occurrence of fibroids, current research, treatment methods, and the causes and alleviation of pain associated with fibroids. The program would also examine symptoms and effects of fibroids on women of color, with a specific focus on identifying barriers to care and recommending ways to improve treatment access.
The bill directs the department to produce recommendations on treatment development and on removing barriers to diagnosis and treatment, including barriers that disproportionately affect women of color. It is a research-and-policy bill rather than a direct benefits or coverage mandate, and it would take effect 60 days after becoming law.
Impact
The bill would add a new section 267-c to the Public Health Law, creating a formal state program for fibroid research and evaluation. Its practical effect would be to require the Department of Health to gather information, assess treatment access, and issue recommendations, potentially informing future legislation, public health initiatives, or clinical guidance. It does not itself change insurance coverage, mandate treatment, or create a new entitlement, but it would establish a state-level framework for studying a condition that disproportionately affects women, especially women of color.
Sentiment
The available voting history suggests strong support: the Senate Women's Issues Committee approved the bill unanimously, 7-0, and there are no recorded dissenting committee remarks in the provided materials. The bill’s framing around women’s health, pain management, and racial disparities indicates a broadly sympathetic policy goal, with the committee action reflecting favorable sentiment toward further study and access improvements.
Contention
No specific opposition is documented in the provided transcripts or vote record. The main policy issues embedded in the bill are the scope of the study, how the department will identify and address barriers to care, and the emphasis on women of color as a distinct population facing access disparities. Any contention would likely center on whether a study program is sufficient versus more direct action, and on how findings might be used to address treatment access, but those concerns are not explicitly recorded here.
Same As
Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Establishes the statewide fibroid study program to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Establishes the fibroid study fund to expend moneys to the department of health to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.
Establishes a uterine fibroids awareness and education program on the symptoms, diagnosis and treatment of uterine fibroids and the elevated risk for minority women.